NRG Therapeutics selects Domainex for project aimed at finding candidate for neurogenerative disorders
A neuroscience company targeting mitochondrial dysfunction has teamed up with an organization developing small molecule…
A neuroscience company targeting mitochondrial dysfunction has teamed up with an organization developing small molecule…
BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, has…
UK neuroscience company NRG Therapeutics Ltd has received a Biomedical Catalyst (BMC) award to fund…
Effective therapies for neurodegenerative diseases like Alzheimer’s are urgently needed. But developing new drugs is…
Last month, European biotechs Ipsen and AC Immune announced multi-million euro deals to acquire or…
Despite decades of research, effective treatments for Parkinson’s disease are proving elusive. Could immunotherapy finally…
The Bordeaux-based company Treefrog Therapeutics has opened an industrial demonstration plant with the aim of…
Modag has developed a candidate drug targeting the neurodegenerative disease multiple system atrophy, which it…
The French company Treefrog Therapeutics has raised over €7M in Series A investment to develop…
The UK biotech Mission Therapeutics has teamed up with AbbVie to develop new drugs to…
The biotech company United Neuroscience has developed a candidate Parkinson's disease vaccine that targets a…
A gene therapy for Parkinson's disease developed by Swiss biotech Axovant has been used on…